DE20205184U1 - Blutfettsenker zur oralen Einnahme - Google Patents

Blutfettsenker zur oralen Einnahme

Info

Publication number
DE20205184U1
DE20205184U1 DE20205184U DE20205184U DE20205184U1 DE 20205184 U1 DE20205184 U1 DE 20205184U1 DE 20205184 U DE20205184 U DE 20205184U DE 20205184 U DE20205184 U DE 20205184U DE 20205184 U1 DE20205184 U1 DE 20205184U1
Authority
DE
Germany
Prior art keywords
mixture
substances according
vitamin
powder
omega
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE20205184U
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE20205184U priority Critical patent/DE20205184U1/de
Priority claimed from DE10214005A external-priority patent/DE10214005A1/de
Publication of DE20205184U1 publication Critical patent/DE20205184U1/de
Priority to ES200300718A priority patent/ES2208131B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Description

Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt
Der Beschreibungstext wurde nicht elektronisch erfaßt

Claims (8)

1. Substanzgemisch zur oralen Einnahme, dadurch gekennzeichnet, dass in einer Tages­ portion 5-30 g Pektin und/oder Guar Pulver und 1-3 g Omega-3-Fettsäuren EPA und DHA Pulver oder Mikrokapseln, auch als Fischöl, gemischt sind.
2. Substanzgemisch nach Anspruch 1, dadurch gekennzeichnet, dass zusätzlich 50-1000 mg Vitamin C und 25-500 mg TÄ (Tocopherol-Äquivalent) Vitamin E enthalten sind.
3. Substanzgemisch nach Anspruch 1-2, dadurch gekennzeichnet, dass zusätzlich 10-60 mg Selen und/oder 5-30 mg Zink und/oder 100-200 µg Chrom enthalten sind.
4. Substanzgemisch nach Anspruch 1-3, dadurch gekennzeichnet, dass zusätzlich 3-10 g Arginin enthalten sind.
5. Substanzgemisch nach Anspruch 1-4, dadurch gekennzeichnet, dass alle Wirkstoffe in einem Pulver, Granulat oder Kapsel enthalten sind oder aber Teile davon als z. B. Tablette, Dragee oder Kapsel in einem Kombi-Pack beigefügt sind.
6. Substanzgemisch nach Anspruch 1-5, dadurch gekennzeichnet, dass das Verhältnis der Omega-3-Fettsäuren von EPA zu DHA mindestens 2 zu 3 bis 2 zu 5 entspricht.
7. Substanzgemisch nach Anspruch 1-6, dadurch gekennzeichnet, dass die Omega-3- Fettsäuren EPA und DHA als Pulver vorliegen oder mikrover-kapselt sind und mit den Antio­ xidantien Vitamin C und Vitamin E und/oder Rosmann vor Oxidation geschützt sind, aus Algen oder Fischöl stammen und mit einem Aroma, vorzugsweise der Note Nuss-Caramel gegen Fischgeruch und -geschmack geschützt sind.
8. Substanzgemisch nach Anspruch 1-7, dadurch gekennzeichnet, dass es sich um ein diätetisches Lebensmittel für besondere medizinische Zwecke, ein Nahrungsergänzungsmittel oder ein Arzneimittel handelt, in Portionsbeuteln, Tagesrationen oder größeren Gebinden wie z. B. Dosen verpackt ist.
DE20205184U 2002-03-27 2002-03-27 Blutfettsenker zur oralen Einnahme Expired - Lifetime DE20205184U1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE20205184U DE20205184U1 (de) 2002-03-27 2002-03-27 Blutfettsenker zur oralen Einnahme
ES200300718A ES2208131B1 (es) 2002-03-27 2003-03-27 Metodo para la fabricacion de un medicamento reductor de niveles de lipidos en sangre para la administracion oral.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10214005A DE10214005A1 (de) 2002-03-27 2002-03-27 Blutfettsenker zur oralen Einnahme, bestehend aus einem Gemisch aus den Omega-3-Fettsäuren EPA (Eicosapentaensäure) und DHA (Docosapentaensäure) und Pektin und/oder Guar als wirksame Substanzen, sowie gegebenenfalls zusätzlichen Stoffen wie antioxidative Vitamine, Aminosäuren und Spurenelemente
DE20205184U DE20205184U1 (de) 2002-03-27 2002-03-27 Blutfettsenker zur oralen Einnahme

Publications (1)

Publication Number Publication Date
DE20205184U1 true DE20205184U1 (de) 2002-12-19

Family

ID=26011089

Family Applications (1)

Application Number Title Priority Date Filing Date
DE20205184U Expired - Lifetime DE20205184U1 (de) 2002-03-27 2002-03-27 Blutfettsenker zur oralen Einnahme

Country Status (1)

Country Link
DE (1) DE20205184U1 (de)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082249A1 (en) 2002-03-28 2003-10-09 Alcon, Inc. Co-beadlet of dha and rosemary and methods of use
WO2004105742A1 (en) * 2003-06-02 2004-12-09 Isis Innovation Limited Treatment of muscle fatigue
EP1487469A1 (de) * 2002-03-28 2004-12-22 Alcon, Inc. Co-perlchen von dha und rosmarin und anwendungsverfahren
WO2011063775A2 (en) 2009-11-25 2011-06-03 Zentiva, K.S. Pectin complexes of sartans and pharmaceutical compositions based thereon
US9211275B2 (en) 2008-01-04 2015-12-15 Isis Innovation Ltd. Ketone bodies and ketone body esters as blood lipid lowering agents
US9579302B2 (en) 2012-11-05 2017-02-28 Tdeltas Ketone bodies to protect tissues from damage by ionizing radiation
US10051880B2 (en) 2008-08-21 2018-08-21 Oxford University Innovation Limited Hydroxybutyrate ester and medical use thereof
US10660958B2 (en) 2010-02-22 2020-05-26 Tdeltas Limited Nutritional composition
US10821062B2 (en) 2013-03-12 2020-11-03 Tdeltas Limited Compound for use in protecting skin
US11230722B2 (en) 2003-06-03 2022-01-25 Oxford University Innovation Limited Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives
US11566268B2 (en) 2013-03-14 2023-01-31 Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Process for producing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1487469A1 (de) * 2002-03-28 2004-12-22 Alcon, Inc. Co-perlchen von dha und rosmarin und anwendungsverfahren
EP1487469A4 (de) * 2002-03-28 2007-05-09 Alcon Inc Co-perlchen von dha und rosmarin und anwendungsverfahren
WO2003082249A1 (en) 2002-03-28 2003-10-09 Alcon, Inc. Co-beadlet of dha and rosemary and methods of use
WO2004105742A1 (en) * 2003-06-02 2004-12-09 Isis Innovation Limited Treatment of muscle fatigue
US11230722B2 (en) 2003-06-03 2022-01-25 Oxford University Innovation Limited Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives
US10154982B2 (en) 2008-01-04 2018-12-18 Oxford University Innovation Limited Ketone bodies and ketone body esters as blood lipid lowering agents
US11311509B2 (en) 2008-01-04 2022-04-26 Oxford University Innovation Limited Ketone bodies and ketone body esters as blood lipid lowering agents
US9211275B2 (en) 2008-01-04 2015-12-15 Isis Innovation Ltd. Ketone bodies and ketone body esters as blood lipid lowering agents
US10051880B2 (en) 2008-08-21 2018-08-21 Oxford University Innovation Limited Hydroxybutyrate ester and medical use thereof
WO2011063775A2 (en) 2009-11-25 2011-06-03 Zentiva, K.S. Pectin complexes of sartans and pharmaceutical compositions based thereon
WO2011063774A2 (en) 2009-11-25 2011-06-03 Zentiva, K.S. Pectin complexes of steroids and pharmaceutical compositions based thereon
US10660958B2 (en) 2010-02-22 2020-05-26 Tdeltas Limited Nutritional composition
US11571479B2 (en) 2010-02-22 2023-02-07 Tdeltas Nutritional composition
US10478415B2 (en) 2012-11-05 2019-11-19 Tdeltas Limited Ketone bodies to protect tissues from damage by ionizing radiation
US9579302B2 (en) 2012-11-05 2017-02-28 Tdeltas Ketone bodies to protect tissues from damage by ionizing radiation
US11234953B2 (en) 2012-11-05 2022-02-01 Tdeltas Limited Ketone bodies to protect tissues from damage by ionizing radiation
US10821062B2 (en) 2013-03-12 2020-11-03 Tdeltas Limited Compound for use in protecting skin
US11566268B2 (en) 2013-03-14 2023-01-31 Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Process for producing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate

Similar Documents

Publication Publication Date Title
EP1155620B1 (de) Nahrungsergänzungsmittel mit Vitaminen, Mineralien und mehrfach ungesättigten Fettsäuren
AU2001256142A1 (en) A nutritional composition for dietary supplements
DE20205184U1 (de) Blutfettsenker zur oralen Einnahme
US8067052B2 (en) Nutritional composition and a container for the convenient transport and storage of the nutritional composition
US6773715B1 (en) Preparation and use of solidified oils
CA2354215C (en) Edible fat based flakes
CA2745267A1 (en) Iron supplement composition
DE20214827U1 (de) Leistungsförderer für Sportler zur oralen Einnahme
DE20204847U1 (de) Mikronährstoffkombinationsprodukt, geeignet für die nutritive Ergänzung als Antioxidanz
JPH0731417A (ja) カプセル栄養補助食品
Ng Omega-3 fatty acids: Potential sources in the Malaysian diet with the goal towards achieving recommended nutrient intakes
Minnis et al. Oily fish and fish oil supplements in the prevention of coronary heart disease
RU2284707C1 (ru) Биологически активная добавка к пище
FR2747017A1 (fr) Complement alimentaire
DE10244907A1 (de) Leistungsförderer für Sportler zur oralen Einnahme bestehend aus einem Gemisch aus den Omega-3-Fettsäuren EPA/DHA und L-Carnitin als wirksame Substanzen, sowie gegebenenfalls zusätzlichen Stoffen wie antioxidative Vitamine, Aminosäuren und Spurenelemente
JP2002253158A (ja) 大豆粉組成物及び牛乳用添加剤
DE20204844U1 (de) Mikronährstoffkombinationsprodukt, geeignet für die nutritive Ergänzung bei einem erhöhten Bedarf an Mikronährstoffen, insbesondere bei Personen mit Herz-Kreislauf-Erkrankungen
JPS6115648A (ja) 油脂類食品
Arens Fish and heart disease
US20170348271A1 (en) Glyceryl laurates and methods of using the same
Howe ω3 Fatty Acids-An Australian Perspective
DE20105126U1 (de) Fischöl zur oralen Einnahme
Rahim et al. Omega-3-Enriched and Oxidative Stable Mayonnaise Formulated with Spray-Dried Microcapsules of Chia and Fish Oil Blends
Harris Omega-3 Polyunsaturated Fatty Acids and Coronary Heart Disease Prevention
JP6018712B2 (ja) 不飽和脂肪酸の吸収促進剤

Legal Events

Date Code Title Description
R207 Utility model specification

Effective date: 20030130

R409 Internal rectification of the legal status completed
R150 Utility model maintained after payment of first maintenance fee after three years

Effective date: 20050421

R157 Lapse of ip right after 6 years

Effective date: 20081001

R151 Utility model maintained after payment of second maintenance fee after six years

Effective date: 20081215

R158 Lapse of ip right after 8 years

Effective date: 20101001